Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid Carcinoma

NCT00210041 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Genital Neoplasms, Male

Interventions

DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

Institut Claudius Regaud